News
ABLYNX AND MERCK SERONO SELECT A NOVEL NANOBODY CANDIDATE, ALX-0761, FOR PRE-CLINICAL DEVELOPMENT
by Hugin
December 12, 2011
Regulated information - Ageas reports on the progress of share buy-back programme
by Hugin
December 12, 2011
Pöyry manages the Urgent Water Supply and Sanitation Rehabilitation Programme in Zimbabwe
by Hugin
December 12, 2011
TRADING PACES: QuantHouse Connects into Swiss Exchange
by Securities Industry News
December 12, 2011
Ahlstrom acquires 49 percent stake in U.S. battery separator company Porous Power Technologies
by Hugin
December 12, 2011
Aprea announces continuation of clinical Phase I/II-study of APR-246 in patients with leukemia
by Hugin
December 12, 2011
Imtech: technology partner for energy efficiency in two high-tech research institutes in Sweden
by Hugin
December 12, 2011
MediGene: Veregen® Marketing Approval Process Initiated for 17 Additional European Countries
by Hugin
December 12, 2011
East Capital Explorer AB - Report of repurchase of own shares in East Capital Explorer
by Hugin
December 12, 2011
Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications
by Hugin
December 12, 2011
Bayfield Ventures Corp. : Bayfield Reports 7.2m of 656.88 g/t Ag in Rainy River, North-western Ontario
by Hugin
December 12, 2011
Disclosure pursuant to transparency legislation in relation to notifications KBC Group
by Hugin
December 9, 2011
FinRoad Rating System
Confidential FinRoad Rating
AAA : High quality contact
AA : Good quality contact
A : Average quality contact
B : Non-investment rating
D : High Risk Contact
Improve Trading Trustfulness


What is FinRoad?
FinRoad operates an online international business and social network for financial markets professionals.
Use our smart tools should you wish to
Use our smart tools should you wish to
- Buy or Sell
- Find a Job
- Recruit
- Invest or Raise Funds

